SCHEMBL31284048

SCHEMBL31284048

Nc1ccc(C(F)(F)F)c(-n2ncc(F)n2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ GLA P06280 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KIF11 P52732 1/20 0.38
▸ MAPT P10636 3/20 0.36
▸ TP53 P04637 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ NR1H2 P55055 1/20 0.31
▸ KDM4E B2RXH2 3/20 0.31
▸ MEN1 O00255 3/20 0.31
▸ ALDH1A1 P00352 3/20 0.31
▸ KMT2A Q03164 3/20 0.31
▸ AR P10275 2/20 0.31
▸ HPGD P15428 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31284854 0.85 GAA (0.40) TSHRGAAGLAPOLBKIF11
SCHEMBL30946489 0.85 MAPT (0.41) TSHRGAAGLAPOLBKIF11
SCHEMBL30946430 0.79 GAA (0.50) TSHRGAAGLAPOLBKIF11
SCHEMBL14320657 0.79 GAA (0.50) TSHRGAAGLAPOLBKIF11
SCHEMBL31284697 0.78 CYP3A4 (0.38) TSHRGAAPOLBMAPTTP53
SCHEMBL31284325 0.76 PTGS1 (0.38) POLBMAPTMAPK1MEN1ALDH1A1
SCHEMBL31284763 0.69 TDO2 (0.45) TSHRGAAGLAPOLBKIF11
SCHEMBL19817407 0.67 GAA (0.52) TSHRGAAGLAPOLBKIF11
SCHEMBL30517118 0.67 GAA (0.52) TSHRGAAGLAPOLBKIF11
SCHEMBL30946425 0.67 NT5E (0.35) CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743085-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics, Inc. (US) 2026-05-20 — — EP disclosed
WO-2025019357-A2 COMPOUNDS, COMPOSITIONS, AND METHODS NICO THERAPEUTICS, INC. (US) 2025-01-23 — — WO disclosed
Send feedback